Changqin Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Changqin Hu has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Jing-Pu Zhang
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
14 shared publications Ying Han
NHC Key Laboratory of Biotechnology of Antibiotics, Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
12 shared publicationsXia Zhang
Key Laboratory for Quality Research and Evaluation of Chemical Drugs, National Institutes for Food and Drug Control, Beijing, 102629, China
10 shared publicationsBo Chen
Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, NHC Key Lab Biotechnol Antibiot, Beijing Key Lab Antimicrobial Agents,Dept Pharmac, Beijing 100050, Peoples R China
4 shared publicationsJin Li
National Institutes for Food and Drug Control, 100050 Beijing, China
4 shared publicationsShangchen Yao
National Institutes for Food and Drug Control (NIFDC), Beijing, China
4 shared publications
Latest Publications
- Open Access
- 28 November 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-9
Research on storage stability differences between ceftriaxone sodium products
The conditions and mechanisms leading to stability differences between ceftriaxone sodium products were examined to ensure drug quality and efficacy. We used a combination of powder X-ray diffraction and thermogravimetric analysis to examine the differences between preparations for injection from different pharmaceutical processes to elucidate the changed processes by exposing samples to different humidity and high-temperature conditions. Water loss or absorption due to varying environmental humidity levels did not adversely affect the crystal structure, but could lead to the reversible redistribution of hepta-hydrate in the unit cell of generic products, causing its stability change. The irreversible distribution of hydrate may occur when generic drugs stored at 25 °C, whereas the brand-name products remained stable at 40 °C. Therefore, generic ceftriaxone sodium and its powder preparations would be acceptable by better controlled sealing and storing under cool conditions during storage period to meet the efficacy and stability.
- 28 November 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-9
Open AccessResearch on storage stability differences between ceftriaxone sodium products
The conditions and mechanisms leading to stability differences between ceftriaxone sodium products were examined to ensure drug quality and efficacy. We used a combination of powder X-ray diffraction and thermogravimetric analysis to examine the differences between preparations for injection from different pharmaceutical processes to elucidate the changed processes by exposing samples to different humidity and high-temperature conditions. Water loss or absorption due to varying environmental humidity levels did not adversely affect the crystal structure, but could lead to the reversible redistribution of hepta-hydrate in the unit cell of generic products, causing its stability change. The irreversible distribution of hydrate may occur when generic drugs stored at 25 °C, whereas the brand-name products remained stable at 40 °C. Therefore, generic ceftriaxone sodium and its powder preparations would be acceptable by better controlled sealing and storing under cool conditions during storage period to meet the efficacy and stability.
- Open Access
- 18 October 2023
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 11, 1270737
Characterization of enteric-coated erythromycin tablets by Raman mapping and its pharmaceutical evaluation
Enteric tablet coating thickness is a critical quality attribute of the coating process that can affect dissolution behavior in vitro as well as release in vivo. Raman mapping offers unique advantages in analyzing the distribution of active pharmaceutical ingredients and excipients in formulations. In this study, Raman mapping was used to characterize the coating of enteric-coated erythromycin tablets coated by two different processes and compare the differences in their coating formulation, thickness, and uniformity. Furthermore, we aimed to select the appropriate pH of the dissolution medium at which the coating slowly cracks to release the drug and determine the dissolution profile. The differences in the coating thickness and uniformity of the two products resulted in differences in dissolution behavior. Although there are differences in the coating processes for the two types of enteric-coated erythromycin tablets, the thickness of the outer coating on the side is a critical quality attribute in both processes. The outer coating of product A is relatively thick, and the thickness of the outer coating on the side affects the dissolution amount. The outer coating of product B is relatively thin, resulting in a short cracking time and large variation and a significant difference in the initial dissolution amounts between tablets. Raman mapping can be used to analyze the differences in coating formulations and for process evaluation.
- 18 October 2023
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 11, 1270737
Open AccessCharacterization of enteric-coated erythromycin tablets by Raman mapping and its pharmaceutical evaluation
Enteric tablet coating thickness is a critical quality attribute of the coating process that can affect dissolution behavior in vitro as well as release in vivo. Raman mapping offers unique advantages in analyzing the distribution of active pharmaceutical ingredients and excipients in formulations. In this study, Raman mapping was used to characterize the coating of enteric-coated erythromycin tablets coated by two different processes and compare the differences in their coating formulation, thickness, and uniformity. Furthermore, we aimed to select the appropriate pH of the dissolution medium at which the coating slowly cracks to release the drug and determine the dissolution profile. The differences in the coating thickness and uniformity of the two products resulted in differences in dissolution behavior. Although there are differences in the coating processes for the two types of enteric-coated erythromycin tablets, the thickness of the outer coating on the side is a critical quality attribute in both processes. The outer coating of product A is relatively thick, and the thickness of the outer coating on the side affects the dissolution amount. The outer coating of product B is relatively thin, resulting in a short cracking time and large variation and a significant difference in the initial dissolution amounts between tablets. Raman mapping can be used to analyze the differences in coating formulations and for process evaluation.
- 27 December 2022
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 15 (5) , 639-647
Developing an improved UHPLC method for impurity profile analysis of ceftriaxone using analytical quality by design
A new UHPLC method was developed based on the quality-by-design principle which could serve as a reference for developing future versions of the pharmacopoeia standards.
- 27 December 2022
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 15 (5) , 639-647
Developing an improved UHPLC method for impurity profile analysis of ceftriaxone using analytical quality by design
A new UHPLC method was developed based on the quality-by-design principle which could serve as a reference for developing future versions of the pharmacopoeia standards.
- Open Access
- 24 August 2022
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 243, 113981
Systems assessment of statins hazard: Integrating in silico prediction, developmental toxicity profile and transcriptomics in zebrafish
- 24 August 2022
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 243, 113981
Open AccessSystems assessment of statins hazard: Integrating in silico prediction, developmental toxicity profile and transcriptomics in zebrafish
- Open Access
- 1 January 2022
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 229, 113106
Hazard assessment of beta-lactams: Integrating in silico and QSTR approaches with in vivo zebrafish embryo toxicity testing
- 1 January 2022
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 229, 113106
Open AccessHazard assessment of beta-lactams: Integrating in silico and QSTR approaches with in vivo zebrafish embryo toxicity testing
- Open Access
- 25 June 2021
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 12 (3) , 481-488
Discussion on the dimerization reaction of penicillin antibiotics
- 25 June 2021
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 12 (3) , 481-488
Open AccessDiscussion on the dimerization reaction of penicillin antibiotics
- Open Access
- 17 May 2021
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 9
Elemental Impurities in Pediatric Calcium Carbonate Preparations-High Throughput Quantification and Risk Assessment
Calcium carbonate which is extracted from the Earth in combination with other mineral impurities, is largely used in preparations for pediatric supplements. Elemental impurities in drug products pose toxicological concerns without therapeutic benefits. Thus, it is very urgent to assess the safety of chronic exposure to elements that may be present in trace amounts. In the present study, we developed high throughput ICP-MS method for the quantitative determination of 62 elemental impurities in high matric calcium carbonate samples and validated according to USP 233. Calcium carbonate preparations which state clearly used for child (including neonates, infants, toddlers and children) from 9 manufactures and two types of raw materials (light calcium carbonate and ground calcium carbonate) were investigated in terms of the content and variability of 62 elemental impurities. According to the results, ground calcium carbonate was more suitable to be used in pediatric preparations concerning elemental impurities. Parts of elemental impurities in CaCO3 preparations which are derived from the raw materials and the preparation process, may cause potential risks for children. These results indicate that it is necessary to establish a modern instrumental analysis method to evaluate and control elemental impurities in CaCO3 raw materials and preparations.
- 17 May 2021
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 9
Open AccessElemental Impurities in Pediatric Calcium Carbonate Preparations-High Throughput Quantification and Risk Assessment
Calcium carbonate which is extracted from the Earth in combination with other mineral impurities, is largely used in preparations for pediatric supplements. Elemental impurities in drug products pose toxicological concerns without therapeutic benefits. Thus, it is very urgent to assess the safety of chronic exposure to elements that may be present in trace amounts. In the present study, we developed high throughput ICP-MS method for the quantitative determination of 62 elemental impurities in high matric calcium carbonate samples and validated according to USP 233. Calcium carbonate preparations which state clearly used for child (including neonates, infants, toddlers and children) from 9 manufactures and two types of raw materials (light calcium carbonate and ground calcium carbonate) were investigated in terms of the content and variability of 62 elemental impurities. According to the results, ground calcium carbonate was more suitable to be used in pediatric preparations concerning elemental impurities. Parts of elemental impurities in CaCO3 preparations which are derived from the raw materials and the preparation process, may cause potential risks for children. These results indicate that it is necessary to establish a modern instrumental analysis method to evaluate and control elemental impurities in CaCO3 raw materials and preparations.
- 1 May 2021
- Published by Elsevier in Environmental Pollution
- Vol. 277, 116779
In vivo and in silico evaluations of survival and cardiac developmental toxicity of quinolone antibiotics in zebrafish embryos (Danio rerio)
- 1 May 2021
- Published by Elsevier in Environmental Pollution
- Vol. 277, 116779
In vivo and in silico evaluations of survival and cardiac developmental toxicity of quinolone antibiotics in zebrafish embryos (Danio rerio)
- Open Access
- 4 November 2020
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 11 (5) , 588-595
A strategy for population pharmaceutical quality assessment based on quality by design
- 4 November 2020
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 11 (5) , 588-595
Open AccessA strategy for population pharmaceutical quality assessment based on quality by design
- 1 September 2020
- Published by Elsevier in Carbohydrate Polymers
- Vol. 244, 116460
A Raman imaging-based technique to assess HPMC substituent contents and their effects on the drug release of commercial extended-release tablets
- 1 September 2020
- Published by Elsevier in Carbohydrate Polymers
- Vol. 244, 116460
A Raman imaging-based technique to assess HPMC substituent contents and their effects on the drug release of commercial extended-release tablets